BioCentury | Oct 13, 2017
Finance

Repurposing Recursion

...the B round included existing investors Lux Capital, Obvious Ventures, Epic Ventures, AME Cloud Ventures, Advantage Capital...
BioCentury | Oct 10, 2017
Company News

Recursion, Takeda enter rare disease discovery partnership

...with participation from fellow existing investors Lux Capital, Obvious Ventures, Epic Ventures, AME Cloud Ventures, Advantage Capital...
BioCentury | Oct 26, 2015
Financial News

Rheonix completes venture financing

...completed: 2015-10-20 Type: Venture financing Raised: $28.6 million Investors: Rand Capital Corp.; Cayuga Venture Fund; Advantage Capital...
BioCentury | Nov 12, 2012
Financial News

New Haven Pharmaceuticals completes venture financing

...completed: 10/29/12 Type: Venture financing Raised: $6.6 million Investors: Connecticut Innovations; EJ Funds; Kuzari Group; Advantage Capital...
BioCentury | Jun 13, 2011
Financial News

Esperance completes venture financing

...financing Raised: Not disclosed Investors: Sanofi ; Louisiana Fund; Themelios Ventures Partners; Research Corp. Technologies; Advantage Capital...
BioCentury | Jun 8, 2007
Financial News

Singulex raises $19.1 million

...a series D round led by OrbiMed Advisors. Existing investors Fisk Ventures; Prolog Ventures; and Advantage Capital...
Items per page:
1 - 6 of 6
BioCentury | Oct 13, 2017
Finance

Repurposing Recursion

...the B round included existing investors Lux Capital, Obvious Ventures, Epic Ventures, AME Cloud Ventures, Advantage Capital...
BioCentury | Oct 10, 2017
Company News

Recursion, Takeda enter rare disease discovery partnership

...with participation from fellow existing investors Lux Capital, Obvious Ventures, Epic Ventures, AME Cloud Ventures, Advantage Capital...
BioCentury | Oct 26, 2015
Financial News

Rheonix completes venture financing

...completed: 2015-10-20 Type: Venture financing Raised: $28.6 million Investors: Rand Capital Corp.; Cayuga Venture Fund; Advantage Capital...
BioCentury | Nov 12, 2012
Financial News

New Haven Pharmaceuticals completes venture financing

...completed: 10/29/12 Type: Venture financing Raised: $6.6 million Investors: Connecticut Innovations; EJ Funds; Kuzari Group; Advantage Capital...
BioCentury | Jun 13, 2011
Financial News

Esperance completes venture financing

...financing Raised: Not disclosed Investors: Sanofi ; Louisiana Fund; Themelios Ventures Partners; Research Corp. Technologies; Advantage Capital...
BioCentury | Jun 8, 2007
Financial News

Singulex raises $19.1 million

...a series D round led by OrbiMed Advisors. Existing investors Fisk Ventures; Prolog Ventures; and Advantage Capital...
Items per page:
1 - 6 of 6